Delivery Order SPE2DB22D3004-SPE2DB25FQ90A
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on August 26, 2025, by the Defense Logistics Agency (DLA) for the supply of Fluorometholone 0.1% eye drops in a 5 mL unit, with a ceiling value of $2,763.79. This competitive award carries firm fixed pricing and is expected to be completed by August 27, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ml units. This $25,662.04 firm fixed-price delivery order has an ultimate completion date of September 16, 2025, and will be performed in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating the contractor's capability to compete for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,471.68 to AmerisourceBergen Drug Corp for the supply of Fluorometholone 0.1% eye drops (10mL) on September 26, 2025, with an ultimate completion date of September 29, 2025. This contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ml units, with a contract ceiling value of $2,476.47. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Fluorometholone 0.1% eye drops in 10 mL units, with a ceiling value of $9,834.86. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fluorometholone 0.1% eye drops in 5ML quantities under a firm fixed price contract type. The award, announced on May 12, 2025, carries a ceiling value of $30,064.98 with an ultimate completion date of May 13, 2025. This non-set-aside competitive award reflects AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements and will be performed at the company's...
- The Defense Logistics Agency awarded a $1,178.86 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluorometholone 0.1% eye drops (5mL). This is a firm fixed price, competitively awarded contract with a completion date of August 8, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's capability to compete in open federal procurement processes. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ml quantities, valued at $5,610.45 under a firm fixed-price contract type. This award represents a non-set-aside, competitively awarded procurement and is classified as a child contract, indicating it falls under a larger indefinite delivery vehicle. The place of performance is located in Conshohocken, Pennsylvania, where...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,625.86 firm fixed-price delivery order is for the supply of Fluorometholone 0.1% eye drops. The contract has an ultimate completion date of December 12, 2024 and is not associated with any set-aside requirements. Amerisourcebergen also holds a larger $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,145.48 to AmerisourceBergen Drug Corp for the supply of Fluorometholone 0.1% eye drops in 5ml quantities. The contract, finalized on June 17, 2025, with an ultimate completion date of June 18, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ90ADelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ML units with a ceiling value of $2,763.31. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support military and federal healthcare systems worldwide. The firm's federal contract portfolio demonstrates extensive experience fulfilling pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/24/25 |